Health Care · owned by 1 fund manager
Who owns Immunovant (IMVT)?
1 of the 22 fund managers we track hold Immunovant, worth $4M combined as of Q2 2026. David Einhorn has the biggest bet at 0.1% of the portfolio.
Ownership summary
Fund manager owners
1 / 22
0 opened new positions
Combined value
$4M
At quarter-end prices
Biggest weight
0.1%
David Einhorn
Buyers / sellers
0 / 0
Changes in Q2 2026
Smart money take
Why it matters
When several investors with very different styles own the same company, it’s often worth a closer look. Immunovant appears in 1 of our 22 portfolios.
- Largest holder: David Einhorn (0.1% of portfolio)
- 0 managers bought or added this quarter
- 0 managers trimmed or sold out
- Company insiders in Q3 2026: no open-market buys, sold $1M
This is not a recommendation. Do your own research.
Fund managers who own IMVT
SEC 13F · Q2 2026| Investor | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| David Einhorn Greenlight Capital | 0.09% | Hold | 93,520 | $4M |
Coming soon · QWERTx Pro
Professionally managed portfolios, built around your life.
We are building QWERTx Pro: portfolios matched to your risk profile and time horizon, managed by experienced financial advisors. Join the waitlist to hear first when it launches.
